Antibodies | Top 10 Cited Articles in 2022

“Antibodies against Platelet Factor 4 and Their Associated Pathologies: From HIT/HITT to Spontaneous HIT-Like Syndrome, to COVID-19, to VITT/TTS”
by Emmanuel J. Favaloro, Leonardo Pasalic and Giuseppe Lippi
Antibodies 2022, 11(1), 7; https://doi.org/10.3390/antib11010007
Available online: https://www.mdpi.com/2073-4468/11/1/7

“Development of a Novel Anti-EpCAM Monoclonal Antibody for Various Applications”
by Guanjie Li, Hiroyuki Suzuki, Teizo Asano, Tomohiro Tanaka, Hiroyoshi Suzuki, Mika K. Kaneko and Yukinari Kato
Antibodies 2022, 11(2), 41; https://doi.org/10.3390/antib11020041
Available online: https://www.mdpi.com/2073-4468/11/2/41

“Immune- and Non-Immune-Mediated Adverse Effects of Monoclonal Antibody Therapy: A Survey of 110 Approved Antibodies”
by Brian A. Baldo
Antibodies 2022, 11(1), 17; https://doi.org/10.3390/antib11010017
Available online: https://www.mdpi.com/2073-4468/11/1/17

“Cellular, Antibody and Cytokine Pathways in Children with Acute SARS-CoV-2 Infection and MIS-C—Can We Match the Puzzle?”
by Snezhina Lazova, Yulia Dimitrova, Diana Hristova, Iren Tzotcheva and Tsvetelina Velikova
Antibodies 2022, 11(2), 25; https://doi.org/10.3390/antib11020025
Available online: https://www.mdpi.com/2073-4468/11/2/25

“Functional Changes of Therapeutic Antibodies upon Exposure to Pro-Oxidative Agents”
by Maxime Lecerf, Robin Lacombe, Alexia Kanyavuz and Jordan D. Dimitrov
Antibodies 2022, 11(1), 11; https://doi.org/10.3390/antib11010011
Available online: https://www.mdpi.com/2073-4468/11/1/11

“Kinetics of the Neutralizing and Spike SARS-CoV-2 Antibodies following the Sinovac Inactivated Virus Vaccine Compared to the Pfizer mRNA Vaccine in Singapore”
by Chin Shern Lau, May Lin Helen Oh, Soon Kieng Phua, Ya Li Liang, Yanfeng Li, Jianxin Huo, Yuhan Huang, Biyan Zhang, Shengli Xu and Tar Choon Aw
Antibodies 2022, 11(2), 38; https://doi.org/10.3390/antib11020038
Available online: https://www.mdpi.com/2073-4468/11/2/38

“New Opportunities in Glycan Engineering for Therapeutic Proteins”
by Xiaotian Zhong, Aaron M. D’Antona, John J. Scarcelli and Jason C. Rouse
Antibodies 2022, 11(1), 5; https://doi.org/10.3390/antib11010005
Available online: http://www.mdpi.com/2073-4468/11/1/5

“Construction of a Humanized Artificial VHH Library Reproducing Structural Features of Camelid VHHs for Therapeutics”
by Taihei Murakami, Shigefumi Kumachi, Yasuhiro Matsunaga, Miwa Sato, Kanako Wakabayashi-Nakao, Hidekazu Masaki, Ryo Yonehara, Maiko Motohashi, Naoto Nemoto and Masayuki Tsuchiya
Antibodies 2022, 11(1), 10; https://doi.org/10.3390/antib11010010
Available online: http://www.mdpi.com/2073-4468/11/1/10

“Anti-SARS-CoV-2 Omicron Antibodies Isolated from a SARS-CoV-2 Delta Semi-Immune Phage Display Library”
by Ivette Mendoza-Salazar, Keyla M. Gómez-Castellano, Edith González-González, Ramsés Gamboa-Suasnavart, Stefany D. Rodríguez-Luna, Giovanni Santiago-Casas, María I. Cortés-Paniagua, Sonia M. Pérez-Tapia and Juan C. Almagro
Antibodies 2022, 11(1), 13; https://doi.org/10.3390/antib11010013
Available online: http://www.mdpi.com/2073-4468/11/1/13

“Highly Specific Monoclonal Antibody Targeting the Botulinum Neurotoxin Type E Exposed SNAP-25 Neoepitope”
by Adva Mechaly, Eran Diamant, Ron Alcalay, Alon Ben David, Eyal Dor, Amram Torgeman, Ada Barnea, Meni Girshengorn, Lilach Levin, Eyal Epstein et al.
Antibodies 2022, 11(1), 21; https://doi.org/10.3390/antib11010021
Available online: http://www.mdpi.com/2073-4468/11/1/21